Bridging to transplantation with continuous flow left ventricular assist devices: The Vienna 9-year experience

2008 ◽  
Vol 56 (S 1) ◽  
Author(s):  
S Sandner ◽  
D Zimpfer ◽  
P Zrunek ◽  
B Steinlechner ◽  
A Rajek ◽  
...  
Keyword(s):  
Continuous Flow ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplant

2016 ◽  
Vol 35 (8) ◽  
pp. 1024-1030 ◽  
Author(s):  
Byung-Soo Ko ◽  
Stavros Drakos ◽  
Abdallah G. Kfoury ◽  
Denise Hurst ◽  
Gregory J. Stoddard ◽  
...  
Keyword(s):  
Heart Transplant ◽  
Continuous Flow ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist ◽  
Before And After

scholarly journals Endocrine Challenges in Patients with Continuous-Flow Left Ventricular Assist Devices

Nutrients ◽  
2021 ◽  
Vol 13 (3) ◽  
pp. 861
Author(s):  
Gennaro Martucci ◽  
Federico Pappalardo ◽  
Harikesh Subramanian ◽  
Giulia Ingoglia ◽  
Elena Conoscenti ◽  
...  
Keyword(s):  
Continuous Flow ◽  
Left Ventricular ◽  
Endocrine Function ◽  
Ventricular Assist Devices ◽  
Circulatory Support ◽  
Endocrine Dysfunction ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

Heart failure (HF) remains a leading cause of morbidity, hospitalization, and mortality worldwide. Advancement of mechanical circulatory support technology has led to the use of continuous-flow left ventricular assist devices (LVADs), reducing hospitalizations, and improving quality of life and outcomes in advanced HF. Recent studies have highlighted how metabolic and endocrine dysfunction may be a consequence of, or associated with, HF, and may represent a novel (still neglected) therapeutic target in the treatment of HF. On the other hand, it is not clear whether LVAD support, may impact the outcome by also improving organ perfusion as well as improving the neuro-hormonal state of the patients, reducing the endocrine dysfunction. Moreover, endocrine function is likely a major determinant of human homeostasis, and is a key issue in the recovery from critical illness. Care of the endocrine function may contribute to improving cardiac contractility, immune function, as well as infection control, and rehabilitation during and after a LVAD placement. In this review, data on endocrine challenges in patients carrying an LVAD are gathered to highlight pathophysiological states relevant to this setting of patients, and to summarize the current therapeutic suggestions in the treatment of thyroid dysfunction, and vitamin D, erythropoietin and testosterone administration.

Sa1681 Colonic Lesions Remain Frequent Sources of Gastrointestinal Bleeds in Patients With Continuous-Flow Left Ventricular Assist Devices

2012 ◽  
Vol 75 (4) ◽  
pp. AB242-AB243 ◽  
Author(s):  
Charles W. Shrode ◽  
Jamie L. Kennedy ◽  
Vanessa M. Shami ◽  
Andrew Y. Wang ◽  
James D. Bergin ◽  
...  
Keyword(s):  
Continuous Flow ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist

Driveline Damage and Repair in Continuous‐Flow Left Ventricular Assist Devices: A Systematic Review

2020 ◽  
Author(s):  
Nicholas D. D'Antonio ◽  
Elizabeth J. Maynes ◽  
Robert T. Tatum ◽  
Kyle W. Prochno ◽  
Abhiraj Saxena ◽  
...  
Keyword(s):  
Systematic Review ◽  
Continuous Flow ◽  
Left Ventricular ◽  
Ventricular Assist Devices ◽  
Left Ventricular Assist Devices ◽  
Ventricular Assist ◽  
Assist Devices ◽  
Left Ventricular Assist
Sign in / Sign up

Export Citation Format

Share Document